ClinVar Miner

Submissions for variant NM_016373.4(WWOX):c.1043del (p.Phe348fs)

dbSNP: rs1064795117
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000484968 SCV000570601 likely pathogenic not provided 2019-12-06 criteria provided, single submitter clinical testing Observed with a pathogenic variant on the opposite allele (in trans) in a patient referred for genetic testing at GeneDx with seizures, cortical visual impairment, and global developmental delay; Observed in a patient with seizures, epileptic encephalopathy, spasticity, blindness, and developmental regression referred for genetic testing at GeneDx in the presence of a second pathogenic WWOX variant; Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 67 amino acids are lost and replaced with 56 incorrect amino acids; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge
Labcorp Genetics (formerly Invitae), Labcorp RCV001381454 SCV001579837 pathogenic Developmental and epileptic encephalopathy, 1; Autosomal recessive spinocerebellar ataxia 12 2023-08-24 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the WWOX protein in which other variant(s) (p.Gly372*) have been determined to be pathogenic (PMID: 31780880; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 421407). This premature translational stop signal has been observed in individual(s) with clinical features of epileptic encephalopathy (Invitae). This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Phe348Serfs*57) in the WWOX gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 67 amino acid(s) of the WWOX protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.